Browse by Author

Browse by Year

Browsing publications by Professor Michael Griffin

Newcastle AuthorsTitleYearFull text
Professor Michael Griffin
ICORG 10-14: NEOadjuvant trial in Adenocarcinoma of the oEsophagus and oesophagoGastric junction International Study (Neo-AEGIS)2017
Alexander Phillips
Dr Maziar Navidi
Professor Michael Griffin
Impact of Extent of Lymphadenectomy on Survival, Post Neoadjuvant Chemotherapy and Transthoracic Esophagectomy2017
Professor Michael Griffin
Dr Kate Sumpter
A randomised phase II study of perioperative epirubicin, cisplatin and capecitabine (ECX) +/- lapatinib for operable, HER-2 positive gastric, oesophagogastric junctional (OGJ) or lower oesophageal adenocarcinoma: Results from the UK MRC ST03 lapatinib feasibility study (ISRCTN 46020948)2016
Dr Lorna Dunn
Professor Alastair Burt
Professor Michael Griffin
Columnar Metaplasia in the Esophageal Remnant After Esophagectomy A Common Occurrence and a Valuable Insight Into the Development of Barrett Esophagus2016
Marina Saisana
Professor Michael Griffin
Dr Felicity May
Importance of the type I insulin-like growth factor receptor in HER2, FGFR2 and MET-unamplified gastric cancer with and without Ras pathway activation2016
Barry Dent
Professor Michael Griffin
Shajahan Wahed
Arul Immanuel
Nick Hayes
et al.
Management and outcomes of anastomotic leaks after oesophagectomy2016
Dr Hafez Al-momani
Rhys Jones
Amaran Krishnan
Dr Andrew Robertson
Dr Stephen Bourke
et al.
Microbiological profiles of sputum and gastric juice aspirates in Cystic Fibrosis patients2016
Dr Maziar Navidi
Dr Kate Sumpter
Professor Michael Griffin
Prognostic impact of extracapsular lymph node involvement after neoadjuvant therapy and oesophagectomy2016
Barry Dent
Dr Maziar Navidi
Professor Michael Griffin
Surgical Proficiency in the Era of Centralization2016
Dr Rhona Sinclair
Dr Maziar Navidi
Professor Michael Griffin
Dr Kate Sumpter
The impact of neoadjuvant chemotherapy on cardiopulmonary physical fitness in gastro-oesophageal adenocarcinoma2016
1234567891011